Assessing the Cost of Psychiatric Drugs to the Elderly and Disabled Citizens of the...
ProPublica is well known for creating interesting data bases that allow anyone hooked up to a computer to see by name whether a physician is accepting Big Pharma payments â from dinners to speaking engagements to consulting services. What may be lesser known is that occasionally ProPublica will publish other data that when carefully mined can reveal even more about the use of psychiatric drugs especially when there is a public funding source available.
Study Explores Pain Assessment for Medically Complex, Nonverbal Children
To what extent are healthcare providers equipped to assess nuance in the experiences of pain among nonverbal children?
Facebook Rolls Out AI to Detect Suicidal Posts
From TechCrunch: Facebook's new artificial intelligence technology will now scan all posts for suicidal thoughts and send mental health resources or contact local first-responders for users...
Majority of Pediatric Antidepressant Industry Trials Considered Low Quality
Meta-analyses including studies that detail these trials could be presenting misleading information.
âLawsuits Link Abilify with Compulsive Gamblingâ
Plaintiffs allege that Bristol-Myers Squibb and Otsuka Pharmaceutical failed to warn doctors and patients about the risk for compulsive behaviors when taking the atypical...
FDA Warns About New Impulse-Control Problems Associated With Abilify
Yesterday, the US Food and Drug Administration (FDA) released a warning that the antipsychotic drug aripiprazole or Abilify is associated with compulsive and uncontrollable...
Randomized Controlled Trials of Psychiatric Drugs Tell of Harm Done
The most important data in an RCT is not whether the drug provides a statistically significant benefit over placebo. The most important data is the ânumber needed to treatâ calculation (NNT). For the person considering taking an antidepressant or an antipsychotic, the NNT data provides the âmathâ needed to weigh the potential benefit of taking the drug against the potential harm of doing so.
Study Finds Improved Functioning for âSchizophreniaâ Without Antipsychotics
Long-term treatment with antipsychotic drugs is currently considered the standard treatment for patients diagnosed with âschizophrenia.â A new study challenges this practice, however. The...
Big Pharma Might Be Intentionally Confusing You
From Benzinga: The FDA has suggested that drug commercials may intentionally list potential side effects in such a rapid-fire, overwhelming way that the warning messages...
âWhat Drug Ads Donât Sayâ
For the New York Times, Cornell psychiatrist Richard Friedman proposes new regulations to make direct-to-consumer drug ads reveal the relative price and effectiveness information that...
Is the FDA Withholding Data to Protect a Drug Manufacturer?
From Scientific American: The FDA seems determined to prevent the public from accessing valuable data about the safety, efficacy, and potential adverse effects of the...
âFears That Antipsychotic Drugs Being Used as ‘Chemical Cosh’ in Disability Careâ
An editorial in the Guardian discusses the fact that the number of people with intellectual or learning disabilities âwho are being treated with psychotropic drugs far exceeds those with mental illness.â The authors of a new study examining the overuse of psychotropic drugs on people with learning disabilities, published this month in BMJ, argue: âIf people without mental illness are given psychotropic drugs⌠it is probably to control their behavior.â
PTSD and Psychiatric Medication Linked to Dementia in Older Veterans
Veterans diagnosed with PTSD and taking SSRIs, novel antidepressants, or atypical antipsychotics are more likely to develop dementia.
Certain Antihypertensive Drugs Linked to Mood Disorders
A new study suggests that some antihypertensive drugs are associated with increased risk of bipolar disorder and depression, while other antihypertensive drugs are actually associated with decreased risk.
Biotech Exploits a Loophole in a Federal Transparency Law
From STAT: A small biotech company, AveXis, recently offered a $3,000 honorarium along with paid airfare and lodging to several experts to attend a so-called...
Doctors Launch Sweeping Pharmaceutical Reform Proposal
From Medical Xpress: A group of 21 prominent physicians have released a comprehensive proposal to guarantee everyone access to safe, innovative, and affordable medication. The proposed reforms...
Deprescribing Starts With Shared Decision Making
From The Lown Institute: Many of the current guidelines and tools available for deprescribing medications use a "one-size-fits-all" approach, merely providing lists of harmful drugs...
Researchers Find Bias in Industry-Funded Continuing Medical Education
Industry-funded continuing medical education (CME) influences physicians to prescribe more opioids, focus less on the consequences.
âWould Washingtonâs FDA Fix Cure the Patients or the Drug Industry?â
Legislation is being advanced that would speed up the FDAâs approval process for new drugs and medical devices, according to a report by the Pacific Standard. Pharmaceutical and medical device companies have been lobbying heavily to reduce regulations and are winning over bipartisan support by attaching these measures to increased mental health funding.
Polypharmacy is Compounding the Opioid Epidemic
From The Lown Institute: The recent deaths of several beloved musicians, actors, and other public figures have brought to light the dangers of taking multiple, potentially fatal drugs.
"In...
Trump’s Pick to Run Mental Health
From STAT: President Trump has nominated Dr. Elinore McCance-Katz, a proponent of increased psychiatric treatment for those diagnosed with serious mental illness, to run the Substance...
âA Decade of Questions over a Paxil Study Vindicatedâ
Martha Rosenberg calls the reanalysis of Paxil and Study 329 âa victory for safety activists, medical reporters, the public and freedom of the press.â But, she warns, âmany pro-pill doctors continue to fight evidence of Paxilâs suicide risks and similar SSRIs.â
College Course Offered on Calling out Scientific Crap
From STAT: Two professors at the University of Washington will be offering a new course, "Calling Bullshit In the Age of Big Data." The class...
New Tool Will Make it Easier to Spot Conflicts of Interest
From Vox: PubMed, a search engine for medical abstracts, has begun displaying conflict of interest data in search results. The abstracts now include a Conflict...
âCalifornia Courts Step Up Oversight of Psychotropic Medication Use in Foster Careâ
The Mercury News reports that Californiaâs judicial council is taking major steps to address the rampant use of psychiatric drugs in foster care. The...